Filing activity is concentrated among a small number of large oilfield-service companies. The single largest assignee in this dataset holds 113 of the 503 records in scope, and the top five assignees together hold 50.3% of all records. Beyond the top ten, who hold 72.6% combined, the remaining assignees each hold comparatively few filings, forming a long tail rather than a second cluster of major holders.

Filing peaked at 24 records in 2017 and has declined since. Comparing 2021 (6 filings) to 2024 (1 filing), the last year publication has largely caught up with, activity fell 83%. Because publication lags filing by roughly 18 months, the very low counts shown for 2025 and 2026 are not yet reliable evidence of the field going quiet — but the decline through 2024 is real and predates that lag.

A borate crosslinked fracturing fluid uses a borate ion to link polymer chains, typically guar-based, into a gel viscous enough to carry proppant at high temperature and then break cleanly once the job is finished. The chemistry matters for patent purposes because most of the claim volume in this landscape — 86.1% of the 503 records touch the C09K materials class — sits on exactly this crosslink-and-break mechanism, making it the most heavily defended part of the field.

The thinnest IPC subclasses in this dataset — C08J polymer processing, C07F organo-metallic compounds, C08B polysaccharides, B01F mixing and C12N microorganisms, each under 5% of the 503 records — sit adjacent to the dominant C09K and E21B classes rather than replacing them. That pattern suggests formulation-adjacent process claims, delivery equipment and biopolymer-based systems are less contested than the core crosslinker chemistry itself, though a full freedom-to-operate review is still needed before filing.

US6642185B2 claims a borate crosslinked fracturing fluid breaker mechanism that uses a cation-releasing material to lower the fluid's pH over time, which uncrosslinks the gel and can trigger an accompanying enzyme breaker. It does not block borate crosslinking generally or enzyme breakers generally; it covers the specific combination of a cation-releasing, pH-lowering trigger used to control the timing of the break. Formulations that achieve delayed breaking through a different mechanism, such as encapsulated oxidizers or temperature-triggered breakers without a cation-release step, sit outside its literal claim scope, though a full claim chart is needed to confirm freedom to operate for any specific formulation.